Outcome of LA Versus GA for Staged CEA Prior To CABG

Sponsor
Thomas Aherne (Other)
Overall Status
Completed
CT.gov ID
NCT04901000
Collaborator
University Hospital Birmingham (Other)
44
84

Study Details

Study Description

Brief Summary

A retrospective analysis of all patients that underwent carotid endarterectomy (CEA) for stenotic disease - diagnosed at pre-operative investigation - prior to CABG as staged operation within 6- months.

The rate of postoperative stroke and complications was compared between CEA performed under Local anaesthetic (LA) to those performed under General anaesthetic (GA).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Carotid endarterectomy

Detailed Description

The primary outcome was the rate of postoperative stroke in patients that had staged CEA prior to CABG. This was defined as CEA within a period of 4 weeks prior to CABG.

We retrospectively looked at those patients that fulfilled the inclusion criteria and had CEA performed either under LA (Group A) or under GA (Group B). We measured the 30 days' postoperative stroke rate as the main outcome. We also looked at the rate of intraoperative stroke.

Additionally, we assessed the rate for developing nerve injuries and/or hematoma postoperatively. Finally, we examined the risk for developing postoperative stroke in patients with bilateral significant carotid artery disease that underwent surgery in one side.

Study Design

Study Type:
Observational
Actual Enrollment :
44 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Outcome of Local Versus General Anesthetic for Staged Carotid Endarterectomy Prior To CABG, Cohort Study
Actual Study Start Date :
Oct 1, 2011
Actual Primary Completion Date :
Sep 30, 2018
Actual Study Completion Date :
Sep 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Carotid Endarterectomy under Local Anaesthetic Pre-CABG

Patients that underwent carotid endarterectomy under local anaesthetic prior to coronary artery bypass operations in staged fashion within 6 months.

Procedure: Carotid endarterectomy
Carotid endarterectomy prior to CABG operations either under Local Anaesthetic or under General Anaesthetic.

Carotid Endarterectomy under General Anaesthetic Pre-CABG

Patients that underwent carotid endarterectomy under general anaesthetic prior to coronary artery bypass operations in staged fashion within 6 months.

Procedure: Carotid endarterectomy
Carotid endarterectomy prior to CABG operations either under Local Anaesthetic or under General Anaesthetic.

Outcome Measures

Primary Outcome Measures

  1. Stroke [30 days]

    a transient ischaemic attack (TIA), or a disabling stroke within 30 days of the carotid endarterectomy procedure.

Secondary Outcome Measures

  1. Major bleeding [30 days]

    Major haematoma was defined as a significant bleeding that required the patient to go back to theatre for a secondary procedure.

  2. Minor bleeding [30 days]

    A minor hematoma was defined as bleeding that resulted in bruising and neck swelling without causing significant concerns to require a secondary procedur

  3. Nerve injuries [30 days]

    Either neuropraxia that resolved with time or permanent injuries that resulted in disability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients that had carotid endarterectomy performed in staged fashion within 6 months before a CABG operation.
Exclusion Criteria:
  • Patients diagnosed with symptomatic carotid disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Thomas Aherne
  • University Hospital Birmingham

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thomas Aherne, Site Investigator, National University of Ireland, Galway, Ireland
ClinicalTrials.gov Identifier:
NCT04901000
Other Study ID Numbers:
  • University Hospital Birmingham
First Posted:
May 25, 2021
Last Update Posted:
May 25, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 25, 2021